Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

ABSTRACT: The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and exploratory dose response of paltusotine treatment in subjects with carcinoid syndrome. This study consists of a Randomized Treatment Phase followed by an Open-Label Extension (OLE) Phase.

DISEASE(S): Carcinoid Intestine Tumor,Carcinoid Tumor,Carcinoid Syndrome Diarrhea,Carcinoid Tumor Of Pancreas,Carcinoid Tumor Of Liver,Diarrhea,Carcinoid Syndrome,Neoplasms,0 Sindrome Carcinoide,Malignant Carcinoid Syndrome,Carcinoid Tumor Of Cecum,Carcinoid Tumor Of Ileum,Carcinoid,Pancreatic Neoplasms,Serotonin Syndrome

PROVIDER: 2726811 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR